Skip to main content
Premium Trial:

Request an Annual Quote

Caliper, Covaris Partner on Sequencing Workflow

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today said that it has signed a co-marketing agreement with Covaris to combine technologies aimed at next-generation sequencing workflows.

The Hopkinton, Mass.-based firm said that the partners will leverage Caliper's automation and microfluidics technologies and Covaris' acoustic DNA-shearing platforms to develop automated workflows.

Among Caliper's sample-preparation technologies for next-gen sequencing applications are the LabChip XT for nucleic acid fractionation, the LabChip GX for library quantification and sizing, the recently launched LabChip DS for purity and quality control, the Zephyr Genomics Workstation for automated nucleic acid extraction and reaction setup, and the Sciclone NGS Workstation, which includes validated protocols for library preparation, sequence capture, and sample normalization.

Covaris' isothermal and non-contact sample prep technologies accelerate the process by "providing a highly predictable and reproducible DNA shearing instrumentation, consumables, and applications to the next-gen workflow," according to the Caliper statement.

"This collaboration is a logical next step toward simplifying workflows for scientists challenged with meeting the growing demands of next generation sequencing sample preparation," Caliper President and CEO Kevin Hrusovsky said. "As sequencing technologies move from the lab bench to the clinic, it is critical that integrated solutions offer consistency and sample tracking."

The alliance is the latest in a series for Caliper aimed at expanding its presence in the next-gen sequencing space. Last month, it teamed with NuGen Technologies to co-market their sample preparation products for next-gen sequencing applications. And in October, Caliper signed a co-marketing deal with Illumina to offer Caliper's library sample preparation and analysis and quality control tools with Illumina's genome sequencing platforms.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.